Funding Opportunity RFA-DK-21-003 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to better understand youth-onset type 2 diabetes. A separate FOA (RFA-DK-21-002) invites Clinical Centers to recruit a cohort of early pubertal youth at risk for developing type 2 diabetes and study them through puberty. The ultimate goals of this consortium will be to 1) develop more precise prediction of which individuals are truly at risk for developing youth-onset T2D and identify determinants of progression from prediabetes to T2D so that, ultimately, targeted prevention approaches can be developed and tested; and 2) increase understanding of the physiologic drivers of youth-onset T2D to guide development of more effective strategies to achieve glycemic control and preserve beta cell function.

Funding Opportunity RFA-DK-21-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to ?c?r?e?a?t?e? ?a? ?c?l?i?n?i?c?a?l? consortium to recruit a cohort o?f early pubertal youth at risk for developing type 2 diabetes and study them th?r?o?ugh puberty. The ultimate goal of this undertaking will be to 1) develop more precise prediction of which individuals are truly at risk for developing you?t?h-onset T2D and identify determinants of progression from prediabetes to T2D so that, ultimately, targeted prevention approaches can be developed and tested; and 2) increase understanding ofthe physiologic drivers of youth-onset T2D to guide development of more effective strategies to achieve glycemic control and preserve beta cell function.

Notice NOT-AA-21-041 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-21-013 from the NIH Guide for Grants and Contracts. This FOA invites applications for continuation of the Collaborative Islet Transplantation Registry? (CITR). Since 2001, this Registry has compiled and analyzed islet transplantation data with the intent to capture all clinical activity in North America as well as additional sites in other countries. Currently, data on both allo- and autotransplantation are collected. The registry will collect data and develop and maintain sophisticated databases to be used by the research community for publications? and presentations. CITR will also prepare an annual report available to the public summarizing outcomes of islet transplantation and trends over time as well as conduct an annual CITR meeting for contributing sites. Collection and analysis of this information? will contribute to identifying risk factors and key safety and efficacy determinants of successful? therapy ofislet transplantation as atreatment for patients with type 1 diabetes and pancreatectomy.

Notice NOT-AA-21-040 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-22-021 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support hypothesis-driven research to gain an understanding of the dysregulation of transposable elements (TE) and their contributions to Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) and aging. This FOA encourages applications that investigate causal effects of TE activation in disease and aging and applications that model therapeutic interventions to facilitate the transition of the field from observational discovery towards a deeper mechanistic understanding of the function and regulation of TEs.

Notice NOT-EB-21-021 from the NIH Guide for Grants and Contracts

£32,780-£41,093: Wellcome Sanger Institute: A position is now available for a highly motivated Postdoctoral Fellow to join the research group of Ana Cvejic, Peter Campbell and Open Targets pa... Hinxton, Cambridgeshire

£37,865-£45,359: Wellcome Sanger Institute: The Opportunity: We are looking for a senior bioinformatician (data manager), who has experience of handling large genomic datasets, to look after ... Hinxton, Cambridgeshire

Notice NOT-AA-21-039 from the NIH Guide for Grants and Contracts

Required: PhD degree in epidemiology, bioinformatics, computer science or related area, OR MD with demonstrated advanced training in epidemiology (a minimum of…
From Medical College of Wisconsin - Wed, 14 Jul 2021 15:08:22 GMT - View all Milwaukee, WI jobs

Notice NOT-EB-21-022 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-315 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-21-205 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-19-400. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several FOAs aimed at supporting transformative discoveries that will lead to breakthroughs in understanding human brain function. Guided by the long-term scientific plan, BRAIN 2025: A Scientific Vision, this FOA specifically seeks to support efforts addressing core ethical issues associated with research focused on the human brain and resulting from emerging technologies and advancements supported by the BRAIN Initiative. The hope is that efforts supported under this FOA might be both complementary and integrative with the transformative, breakthrough neuroscience discoveries supported through the BRAIN Initiative.

5.Nimbly adapts bioinformatics tools, visualization packages, and annotation resources to perform accurate research analysis – flexibility and competency in…
From Medical College of Wisconsin - Wed, 14 Jul 2021 03:08:29 GMT - View all Milwaukee, WI jobs

Notice NOT-OD-21-151 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-021 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HL-22-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans. Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ

Organization U.S. Department of Agriculture (USDA) Reference Code USDA-ARS-2021-0183 How to Apply Connect with ORISE...on the GO! Download the new ORISE GO…
From Oak Ridge Associated Universities - Mon, 12 Jul 2021 20:11:45 GMT - View all Kearneysville, WV jobs

Notice NOT-HS-21-017 from the NIH Guide for Grants and Contracts